A DNA scaffold that carries HIV vaccine proteins into the body sharpens the immune response against the virus.
On February 9, Ethris GmbH, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics and vaccines, and the German Center for Infection Research (DZIF), announced a strategic ...
MerryLife Biomedical Inc., a clinical-stage biotechnology company focused on neurodegenerative diseases, today announced positive Phase 1 results for TML-6, its investigational oral therapy for ...
CD Bioparticles launches specialized RNA Synthesis services for researchers to develop next-generation mRNA vaccines, gene therapies, and RNA-based therapeutics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results